Aaron Keay of Allon Therapeutics collects the Grand prix for
best overall investor relations – small cap award from Glenn
Keeling of Laurel Hill Advisory Group
We are celebrating a win this week. Allon Therapeutics – a small biotech company developing drugs to treat Alzheimer’s – won an award for best Investor Relations program. We have been designing and producing their annual reports and website. It was a refreshing change from all the doom and gloom to receive an email of congratulations from the Allon CEO, Gordon McCauley.
“I had the privilege of attending the IR Magazine award event this evening in Toronto to cheer on Aaron. He won the award for Best IR Program of $250-mm market cap companies. It was a big “Academy Awards” like ceremony hosted by the anchor from Business News Network and the award that Aaron won was among the top 4 awards that the whole night built up to.
What is really great is how the awards were selected: a polling firm was hired to take surveys of all the investment analysts, major institutional shareholders, and a selection of retail brokers and asked: “who does it best”? Think about that: of all the publicly traded companies in Canada with a market cap of less than $250-mm, in any sector, our IR program won as the one that tells the story most accurately, effectively, and serves the needs of the investing community. What a compliment for a job really well done.
Please join me in congratulating Aaron and the team.”
I know that Allon put a great deal of work into their IR program. And these days it’s a hard job. The IR Magazine awards recognize this effort. You can see all the winners by visiting the IR Magazine website. And enjoy the good news!